Department of Anesthesiology, Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Anesthesiology. 2010 Jun;112(6):1503-10. doi: 10.1097/ALN.0b013e3181d9cb5e.
Experimental research in cardiac and neuronal tissue has shown that besides volatile anesthetics and xenon, the nonanesthetic noble gas helium also reduces ischemia-reperfusion damage. Even though the distinct mechanisms of helium-induced organ protection are not completely unraveled, several signaling pathways have been identified. Beside the protective effects on heart and brain that are mainly obtained by different pre- and postconditioning protocols, helium also exerts effects in the lungs, the immune system, and the blood vessels. Obviously, this noble gas is biochemically not inert and exerts biologic effects, although until today the question remains open on how these changes are mediated. Because of its favorable characteristics and the lack of hemodynamic side effects, helium is suitable for use also in critically ill patients. This review covers the cellular effects of helium, which may lead to new clinical strategies of tissue salvage in ischemia-reperfusion situations, both within and outside the perioperative setting.
实验研究表明,除了挥发性麻醉剂和氙气,非麻醉性稀有气体氦也可以减少缺血再灌注损伤。尽管氦诱导器官保护的具体机制尚未完全阐明,但已经确定了几种信号通路。除了主要通过不同的预处理和后处理方案获得的对心脏和大脑的保护作用外,氦还对肺、免疫系统和血管发挥作用。显然,这种稀有气体在生化上并非惰性的,会产生生物学效应,尽管直到今天,人们仍然不清楚这些变化是如何介导的。由于其有利的特性和缺乏血液动力学副作用,氦也适用于危重病患者。这篇综述涵盖了氦的细胞效应,这可能导致在缺血再灌注情况下组织保存的新的临床策略,包括围手术期内外。